Item 8.01 Other Events
On
Forward Looking Statements
This Current Report on Form 8-K contains forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995. Such
forward-looking statements include those that express plans, anticipation,
intent, contingencies, goals, targets or future development and/or otherwise are
not statements of historical fact. These statements relate to future events or
future results of operations, including, but not limited to the following
statements: the company's beliefs concerning the safety and effectiveness of
Tempol or the company's other product candidates; the timing of funding for, or
commencement or completion of, any studies or trials relating to Tempol; the
availability of, and the company's success in applying for and obtaining,
government or other funding for studies or trials relating to Tempol or the
timing or amount of any such funding; the results of any future studies or
trials that the company may conduct relating to Tempol; the company's ability to
commercialize the product candidates described in this Report, itself or through
commercialization partners; and other statements concerning our future
operations and activities. These statements are only predictions and involve
known and unknown risks, uncertainties and other factors, which may cause
Adamis' actual results to be materially different from the results anticipated
by such forward-looking statements. There can be no assurances regarding the
outcome of our submission of the IND relating to investigational use of, or
trials or studies relating to, Tempol, regarding the timing or the outcome of
any applications or requests that we may submit for government or other funding
for studies or trials relating to Tempol; concerning the timing or outcome of
any such studies or trials; or that Tempol will be found to be safe and
effective in the treatment of COVID-19 or any other indication. In addition,
forward-looking statements concerning our anticipated future activities assume
that we are able to obtain sufficient funding to support such activities and
continue our operations and planned activities. As discussed in our filings with
the
© Edgar Online, source